Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Studies in vitro suggest that it binds to a regulatory site on the CB1 receptor target
77(13 Suppl):Abstract nr 955
American Chemical Society
v) exhibits terminal elimination half-lives (1
but does not significantly induce degradation of EGFR mutants
Enrofloxacin Catalog No.:M8968-2 Studies in vitro suggest thatEnrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation. It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration dependent, with susceptible bacteria cell death occurring within 2030 minutes of exposure. Enrofloxacin has demonstrated a significant post antibiotic effect for both Gram negative and Gram positive bacteria and is active in both stationary and growth phases of bacterial replication. Product
US$ 997.50
US$ 297.50
US$ 847.50
US$ 1497.50